South Korea
· Delayed Price · Currency is KRW Green Cross Holdings Company Description
Green Cross Holdings Corporation operates as a biotechnology company.
The company provides prescription drugs and over the counter drugs; aseptic fill and finish services for drug manufacturing; and pharmaceutical logistics services.
It also researches and develops plasma derivatives for von Willebrand disease and primary immunodeficiency; vaccines for mRNA flu, anthrax, tetanus, diphtheria, pertussis, tuberculosis, and varicella; recombinant treatments for acquired thrombotic thrombocytopenic purpura, fabry, hemophilia, hunterase, colon cancer, and hunter syndrome; and small molecules for gangliosidosis andalagille’s syndrome.
The company has partnerships and collaborations with biotech companies and academia for development of new drugs and technologies, and clinical trials.
Green Cross Holdings was founded in 1967 and is headquartered in Yongin-Si, South Korea.
| Country | South Korea |
| Founded | 1967 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 154 |
| CEO | Il-Sup Huh |
Contact Details
Address: 107, Ihyeon-ro 30beon-gil Yongin-Si South Korea | |
| Phone | 82 3 1260 9300 |
| Website | gcbiopharma.com |
Stock Details
| Ticker Symbol | 005250 |
| Exchange | Korea Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | KRW |
| ISIN Number | KR7005250006 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Il-Sup Huh Ph.D. | Chairperson and Chief Executive Officer |
| Dr. Eun Chul Huh | President |
| Yong-jun Hur | Vice President and Director |
| Yong-Jun Huh | Vice President and Director |